The global pessary market is poised for significant growth, forecasted to reach $831.3 million by 2032

The global pessary market is set to witness remarkable expansion, fueled by increased awareness of urinary incontinence and pelvic floor disorders. According to a recent report by Future Market Insights, the market size, valued at approximately USD 316 million in 2022, is expected to grow at a solid compound annual growth rate (CAGR) of 10.2% over the next decade. The market is expected to reach an impressive value of USD 831.3 million by 2032.

Pessaries, one of the oldest and most reliable medical devices, continue to play a key role in the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP). These devices, usually made of silicone or rubber, are inserted into the vagina to provide essential support to the pelvic floor muscles, effectively relieving symptoms associated with urinary incontinence and prolapse.

Healthcare providers prescribe pessaries based on factors such as the severity of UI, the presence of pelvic organ prolapse, and the patient’s level of sexual activity to ensure both comfort and effectiveness. Advances in materials and design have led to more personalized and effective treatment options, allowing pessaries to better meet the changing needs of patients.

The rising prevalence of urinary incontinence and pelvic floor disorders, coupled with the aging population, is significantly increasing the demand for pessaries. Moreover, increased patient education and awareness initiatives are expected to further drive the market growth in the coming years.

Manufacturers are prioritizing innovation and product development to address unmet patient needs and improve treatment outcomes. Strategic collaborations between healthcare organizations and industry players are also expected to accelerate advances in pessary technology, improving patient care and treatment effectiveness.

As the global pessary market continues to grow, the importance of continued advances and innovations in medical technology to support patient well-being and quality of life becomes increasingly apparent.

Key conclusions:

The global pessary market is expected to grow significantly in the coming years, driven by the increasing incidence of pelvic organ prolapse and urinary incontinence, as well as the growing awareness of the importance of pessaries as a non-surgical treatment option for these conditions.
North America is expected to remain the largest market for pessaries throughout the forecast period, followed by Europe and the Asia-Pacific region.
Ring pessaries are predicted to be the most popular type of pessary during the forecast period.
It is predicted that silicone pessaries will be the most popular pessary material during the forecast period.
It is expected that in the forecast period the most popular distribution channel for pessaries will be hospital pharmacies.

Key companies covered:

MedGyn Products, Inc.
Cooper Surgical Inc.
Personal Medical Corp.
Panpac Medical Corporation
Smiths Medical
Thomas Medical
Medical Craftsman
Bioteque America, Inc.
Integra LifeSciences Corporation
Arabin GmbH & Co.
Medgyn Products, Inc.
Wallach Surgical Devices

Trends in the pessary market: Discover the full details in our comprehensive report!

Below are some of the recent developments in the pessary industry:

In February 2022, Cooper Companies agreed to buy Cook Medical’s Reproductive Health division, which makes noninvasive devices for the treatment of infertility, obstetrics and gynecology. Cooper will pay a total of $875 million, of which $675 million will be paid at closing and the remaining $200 million will be paid in four annual installments of $50 million.
In February 2022, Theramex, a global pharmaceutical company specializing in women’s health, expanded its initial partnership with Endoceutics to introduce Intrarosa to the Australian market. Intrarosa is the first and only DHEA treatment approved for postmenopausal women with moderate to severe vulvar and vaginal atrophy.
In August 2021, Liv Labs developed a reusable comfort pessary for women that does not require a doctor’s prescription. Patients suffering from urinary incontinence are currently fitted with a pessary that must be worn for six months before removal.

The Liv Labs pessary is soft, smooth and flexible, making it easy to put on and take off. It is made of medical-grade silicone. Women can use it whenever they want, whether it’s all day long or just for a quick trip to the gym.

Market segments covered by the pessary industry analysis:

By type:

Gellhorn
Ring
Donut
Other types

By end use:

Hospitals
Outpatient Surgery Centers
Clinics

By region:

North America
Europe
Asia and Pacific
Middle East and Africa
Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award winner and member of the Greater New York Chamber of Commerce) offers in-depth insights into the factors driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional and local expertise on various industry disciplines and trends in over 110 countries.

Contact us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Apartment 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For commercial inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter| Blogs | YouTube